174 related articles for article (PubMed ID: 6260313)
1. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
Delvin EE; Glorieux FH
Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
[TBL] [Abstract][Full Text] [Related]
2. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF
Am J Dis Child; 1980 Feb; 134(2):140-3. PubMed ID: 6243443
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D metabolism in hypophosphatemic rickets.
Mason RS; Rohl PG; Lissner D; Posen S
Am J Dis Child; 1982 Oct; 136(10):909-13. PubMed ID: 6981996
[TBL] [Abstract][Full Text] [Related]
4. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
Scriver CR; Reade TM; DeLuca HF; Hamstra AJ
N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618
[TBL] [Abstract][Full Text] [Related]
5. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
7. Rickets of prematurity. Supranormal levels of serum 1,25-dihydroxyvitamin D.
Chesney RW; Hamstra AJ; DeLuca HF
Am J Dis Child; 1981 Jan; 135(1):34-7. PubMed ID: 6969986
[TBL] [Abstract][Full Text] [Related]
8. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
Roof BS; Piel CF; Gordan GS
Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
[No Abstract] [Full Text] [Related]
9. Vitamin D metabolite concentrations in vitamin D deficiency. Are calcitriol levels normal.
Chesney RW; Zimmerman J; Hamstra A; DeLuca HF; Mazees RB
Am J Dis Child; 1981 Nov; 135(11):1025-8. PubMed ID: 6271009
[TBL] [Abstract][Full Text] [Related]
10. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and vitamin D dependency.
Tsuchiya Y; Matsuo N; Cho H; Tsubouchi K; Kumagai M; Nishii Y; Nanjoh M; Yamamoto T
Contrib Nephrol; 1980; 22():89-100. PubMed ID: 6967387
[TBL] [Abstract][Full Text] [Related]
12. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
[TBL] [Abstract][Full Text] [Related]
13. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
Yamaoka K; Tanaka H; Kurose H; Shima M; Ozono K; Nakajima S; Seino Y
Bone Miner; 1989 Sep; 7(2):159-69. PubMed ID: 2804451
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
Beer S; Tieder M; Kohelet D; Liberman OA; Vure E; Bar-Joseph G; Gabizon D; Borochowitz ZU; Varon M; Modai D
Clin Endocrinol (Oxf); 1981 Apr; 14(4):395-402. PubMed ID: 6266702
[TBL] [Abstract][Full Text] [Related]
15. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets.
Bettinelli A; Bianchi ML; Mazzucchi E; Gandolini G; Appiani AC
J Pediatr; 1991 Mar; 118(3):372-6. PubMed ID: 1847972
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
Glorieux FH
Metabolism; 1990 Apr; 39(4 Suppl 1):10-2. PubMed ID: 2157942
[TBL] [Abstract][Full Text] [Related]
18. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
Marie PJ; Travers R; Glorieux FH
Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of vitamin D metabolites before and during treatment of vitamin D deficiency rickets in children.
Markestad T; Halvorsen S; Halvorsen KS; Aksnes L; Aarskog D
Acta Paediatr Scand; 1984 Mar; 73(2):225-31. PubMed ID: 6331057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
